HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Anna Gonciarz-Dytman Selected Research

O2-vinyl 1- (2- (carboxylato)pyrrolidin- 1- yl)diazen- 1- ium- 1,2- diolate

7/2015Hepatoselective Nitric Oxide (NO) Donors, V-PYRRO/NO and V-PROLI/NO, in Nonalcoholic Fatty Liver Disease: A Comparison of Antisteatotic Effects with the Biotransformation and Pharmacokinetics.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Anna Gonciarz-Dytman Research Topics

Disease

1Fatty Liver
07/2015
1Non-alcoholic Fatty Liver Disease
07/2015

Drug/Important Bio-Agent (IBA)

1O(2)- vinyl- 1- (pyrrolidin- 1- yl)diazen- 1- ium- 1,2- diolateIBA
07/2015
1O2-vinyl 1- (2- (carboxylato)pyrrolidin- 1- yl)diazen- 1- ium- 1,2- diolateIBA
07/2015
1AcidsIBA
07/2015
1Fatty Acids (Saturated Fatty Acids)IBA
07/2015
1Glucose (Dextrose)FDA LinkGeneric
07/2015
1Nitric Oxide (Nitrogen Monoxide)FDA Link
07/2015